Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00338000
Status:
COMPLETED
Last Update Posted:
2011-02-01
First Post:
2006-06-16
Brief Title:
EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX Epoetin Alfa in Predialysis Patients With Chronic Renal Failure
Sponsor:
Janssen Pharmaceutica NV Belgium
Organization:
Janssen Pharmaceutica NV Belgium
Organization Data
Organization:
Janssen Pharmaceutica NV Belgium
Class:
INDUSTRY
Study ID:
CR012034
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Pharmaceutica NV Belgium
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None